Science

Japanese lab may retract stem cell paper

RIKEN President Ryoji Noyori spoke Friday during a news conference in Tokyo.

Toru Hanai/REUTERS

RIKEN President Ryoji Noyori spoke Friday during a news conference in Tokyo.

TOKYO — A Japanese government-funded laboratory said Friday that it has found ‘‘inappropriate handling’’ of data in a widely heralded stem-cell research paper, but has yet to discover anything that amounts to misconduct.

In an interim report released Friday, the RIKEN research institute said an investigative committee did not find any misconduct in two of the six parts of the paper it is scrutinizing.

Advertisement

RIKEN President Ryoji Noyori, a Nobel laureate in chemistry, said the institute is looking into ‘‘significant discrepancies’’ in the preparation of articles about the research published in January in the scientific journal Nature.

‘‘It may become necessary to demand the withdrawal of the articles,’’ he told a packed news conference in Tokyo.

RIKEN and Nature are investigating allegations of duplicated images of DNA fragments and partial plagiarism.

Three authors of the paper have agreed to a retraction, said Masatoshi Takeichi, head of RIKEN’s Center for Developmental Biology, but a final decision hinges on a consensus of all the authors and the journal itself. Researchers in Boston and Japan conducted the experiments.

The results were seen as a possible groundbreaking method for growing tissue to treat illnesses such as diabetes and Parkinson’s disease using a simple lab procedure.

Advertisement

The institute stressed that the aim of the investigation is solely to determine whether there was any misconduct, and not the veracity of the research itself. Takeichi said verification of the results depends on their reproduction by independent researchers.

Loading comments...
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.